4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Clinical trial NCT04427449 · RECRUITING

Trial details

NCT number: NCT04427449
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancers Which Are CD44v6 Positive

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.